A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
We recently compiled a list of the 10 Firms Fall Amid Disappointing Earnings Performance. In this article, we are going to ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. "This agreement presents an opportunity for Moderna to support and ...
Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results